Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Lantern Pharma Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −3 vs. Q3 2022
- Shares held
- 1.07M
- −370.9K (−25.8%) vs. Q3 2022
- Total value
- $5.40M
- −$1.45M (−21.1%) vs. Q3 2022
- New holders
- 3
- 8 more added
- Sold out
- 6
- 8 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LTRN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $12.0M |
| Q1 2026 | 33 | $2.87M |
| Q4 2025 | 33 | $6.91M |
| Q3 2025 | 30 | $9.89M |
| Q2 2025 | 35 | $7.11M |
| Q1 2025 | 32 | $8.62M |
| Q4 2024 | 32 | $8.00M |
| Q3 2024 | 31 | $4.90M |
| Q2 2024 | 39 | $6.01M |
| Q1 2024 | 34 | $9.75M |
| Q4 2023 | 30 | $4.94M |
| Q3 2023 | 27 | $3.93M |
| Q2 2023 | 25 | $6.50M |
| Q1 2023 | 21 | $5.23M |
| Q4 2022 | 23 | $5.40M |
| Q3 2022 | 26 | $6.84M |
| Q2 2022 | 26 | $8.06M |
| Q1 2022 | 25 | $10.4M |
| Q4 2021 | 33 | $13.1M |
| Q3 2021 | 25 | $15.7M |
| Q2 2021 | 22 | $19.7M |
| Q1 2021 | 24 | $25.5M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Lantern Pharma Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 367,454 | $2.22M | 0.00% | +1350.0% | Added |
| Carlson Capital L P | 138,000 | $833.5K | 0.06% | −30,000−17.9% | Reduced |
| CM Management, LLC | 60,000 | $362.0K | 0.43% | +10,000+20.0% | Added |
| Geode Capital Management, LLC | 57,774 | $348.0K | 0.00% | −135−0.2% | Reduced |
| Redmond Asset Management, LLC | 50,373 | $304.3K | 0.11% | +871+1.8% | Added |
| State Street Corp | 27,752 | $167.6K | 0.00% | 00.0% | Unchanged |
| Wolff Wiese Magana LLC | 27,098 | $163.7K | 0.14% | −3,364−11.0% | Reduced |
| Bank of New York Mellon Corp | 26,480 | $159.9K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 21,100 | $127.0K | 0.00% | −200−0.9% | Reduced |
| BlackRock Inc. | 20,892 | $126.2K | 0.00% | +372+1.8% | Added |
| Citadel Advisors LLC | 19,321 | $116.7K | 0.00% | +6,568+51.5% | Added |
| Sigma Planning Corp | 17,300 | $104.5K | 0.00% | −200−1.1% | Reduced |
| Jane Street Group, LLC | 15,134 | $91.4K | 0.00% | +15,134 | New |
| UBS Group AG | 14,841 | $89.6K | 0.00% | +2,841+23.7% | Added |
| Northern Trust Corp | 12,629 | $76.3K | 0.00% | 00.0% | Unchanged |
| Lynwood Capital Management Inc. | 12,000 | $73.0K | 0.09% | +12,000 | New |
| Wells Fargo & Company | 3,985 | $24.1K | 0.00% | +10.0% | Added |
| Advisor Group Holdings, Inc. | 864 | $5.00K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 300 | $1.81K | 0.00% | −150−33.3% | Reduced |
| Morgan Stanley | 289 | $1.75K | 0.00% | −5−1.7% | Reduced |
| GWM Advisors LLC | 172,838 | $1.04K | 0.00% | +1,819+1.1% | Added |
| Bank of America Corp | 8 | $48 | 0.00% | +8 | New |
| Tower Research Capital LLC (TRC) | 28 | $0 | 0.00% | −3,789−99.3% | Reduced |
| Sanders Morris Harris LLC | 0 | $0 | 0.00% | −365,930−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −14,558−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1,787−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −373−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −87−100.0% | Sold out |
| Bogart Wealth, LLC | 0 | $0 | 0.00% | −75−100.0% | Sold out |